AI assistant
ROSSARI BIOTECH LIMITED — Call Transcript 2024
Jan 16, 2024
59144_rns_2024-01-16_5039e71b-84c2-4f87-ad32-4f7d60214a50.pdf
Call Transcript
Open in viewerOpens in your device viewer
January 16, 2024
| DCS-CRDBSE LimitedFirst Floor, New Trade WingRotunda Building, Phiroze Jeejeebhoy TowersDalal Street, Fort, Mumbai 400001Fax No.2272 3121/2037/2039Stock Code: 543213 | Listing ComplianceNational Stock Exchange of India Ltd.Exchange Plaza, 5th Floor, Plot No. C/1,‘G’ Block, Bandra- Kurla ComplexBandra East, Mumbai 400 051Fax No.2659 8237/8238Stock Code: ROSSARI |
|---|
Dear Sir/Madam,
Sub.: Revised Intimation of Earnings Conference Call for investors and analysts for Q3 FY24
Ref.: Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that an Earnings Conference Call for investors and analysts is being organized by the Company on Tuesday, January 23, 2024 at 04:00 P.M. IST.
The conference call will be initiated with a brief management discussion on the results for quarter and nine months ended December 31, 2023 followed by an interactive Question & Answer session.
Invite in this regard is enclosed for your information and record.
We would further like to submit that revised intimation is only due to some technical error in the link and all other information of the Earnings Conference Call shall remain unchanged.
The same may please be taken on record and suitably disseminated to all concerned.
Thanking you,
Yours Sincerely, For Rossari Biotech Limited
PARUL Digitally signed by PARUL GUPTA Date: 2024.01.16 GUPTA 15:12:16 +05'30' _______________________ Parul Gupta Company Secretary & Compliance Officer Membership No.: A38895
Encl.: as above
==> picture [127 x 72] intentionally omitted <==
Rossari Biotech Limited
Q3 FY24 Earnings Conference Call
Tuesday, January 23, 2024, at 4:00 p.m. IST
Rossari Biotech Limited (Rossari) will host a conference call for investors and analysts on Tuesday, January 23, 2024, at 4:00 pm IST.
The conference call will be initiated with a brief management discussion on the Q3 FY24 results, to be declared on Saturday, January 20, 2024, followed by an interactive Question & Answer session.
Senior Management team of the Company will be present to address the call.
Dial-in details are as follows:
| Timing | 4:00 p.m. IST on Tuesday, January 23, 2023 |
|---|---|
| Universal dial-in | + 91 22 6280 1141 / 7115 8042 |
| Pre-registration (Zero wait time to jointhe call) | To enable participants to connect to the conference callwithout having to wait for an operator, please registerat the below mentioned link: |
Page | 1
About Rossari:
Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a Speciality-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, India, the Company operates strategically located manufacturing facilities at Silvassa and Dahej. The Company offers tailor-made solutions for Home, Personal Care and Performance chemicals (HPPC), Textile speciality chemicals and Animal Health and Nutrition (AHN). With differentiated product offerings, Rossari caters to an array of applications across FMCG, Home care, Industrial Cleaning, Personal Care, Textile Speciality Chemicals, Performance Chemicals, the Animal Health and Nutrition and Pet Care businesses. The Company has an extensive and a dedicated network of distributors spread all over India.
For more information, please visit www.rossari.com OR contact:
Ketan Sablok Anoop Poojari / Mitesh Jain Rossari Biotech Limited CDR India Tel: +91 22 6123 3800 Tel: +91 98330 90434 / 96194 44691 Email: [email protected] Email: [email protected] [email protected]
DISCLAIMER:
Certain statements that may be made or discussed at the conference call may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in economic environment in India and overseas, tax laws, import duties, litigation, labour relations etc. Actual results might differ substantially from those expressed or implied. Rossari Biotech Ltd will not be in any way responsible for any action taken based on such statements and discussions; and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.
Page | 2